JENNIFER LACOURSE: Open Payments
NPI 1023341138 · PLAINVILLE, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$672 in 30 payments from 11 companies in 2025. Trend: 2023 $278 · 2024 $431 · 2025 $672
Food & beverage: $672
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $186 |
| AstraZeneca Pharmaceuticals LP | 6 | $150 |
| PFIZER INC. | 5 | $87 |
| Amgen Inc. | 3 | $74 |
| Merck Sharp & Dohme LLC | 2 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $31 |
| Medtronic, Inc. | 1 | $25 |
| Astellas Pharma US Inc | 1 | $22 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
| Lilly USA, LLC | 1 | $19 |
Products named: Ozempic, AIRSUPRA, EVENITY, PREVNAR 20, TRUMENBA, JASCAYD, Rybelsus, MINIMED 780G.
Industry payments across MA — which companies pay providers there.
